Wordt geladen...
Potential for Therapeutic Benefit among Cystic Fibrosis Populations Excluded from Clinical Trials or Labeling of Marketed Therapies
Remarkable advances in the management of individuals born with cystic fibrosis (CF) would not have been realized without empiric trial and error by CF clinicians with treatments developed and available for other purposes. As the testing and registration of CF-specific treatments have increased, so t...
Bewaard in:
| Gepubliceerd in: | Ann Am Thorac Soc |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Thoracic Society
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5466179/ https://ncbi.nlm.nih.gov/pubmed/27518252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201606-462PS |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|